Drugs / Formoterol-budesonide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01769898 Background | Jul 2013 → Sep 2014 | bronchiectasis | The First Affiliated Hospital of Guangzhou Medical University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Formoterol-budesonide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01769898 ↗ |
| Route | Inhaled | “Inhaled Formoterol-budesonide combined treatment 4.5µg/160µg every 12hours for 24weeks.” NCT01769898 ↗ |